Pathologic Quantification of Connective Tissue Disease-Associated Versus Idiopathic Usual Interstitial Pneumonia

被引:24
|
作者
Cipriani, Nicole A. [1 ]
Strek, Mary [2 ]
Noth, Imre [2 ]
Gordon, Ilyssa O. [1 ]
Charbeneau, Jeff [3 ]
Krishnan, Jerry A. [3 ]
Krausz, Thomas [1 ]
Husain, Aliya N. [1 ]
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60637 USA
[3] Univ Illinois Hosp & Hlth Sci Syst, Dept Pulm Crit Care & Sleep Med, Chicago, IL USA
关键词
COLLAGEN VASCULAR-DISEASE; PULMONARY FIBROSIS; ACUTE EXACERBATION; FIBROBLASTIC FOCI; PROGNOSIS; PATTERNS; FORMS;
D O I
10.5858/arpa.2012-0102-OA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Usual interstitial pneumonia (UIP) is a common chronic interstitial pneumonitis. It can occur idiopathically (I-UIP) or in the setting of systemic connective tissue disease (CTD-UIP). Some studies suggest that CTD-UIP has a better prognosis than I-UIP. The histologic differences between CTD-UIP and I-UIP are not clearly defined. Objective.-The purpose of this study was to evaluate histologic criteria that may differentiate CTD-UIP from I-UIP, including fibroblastic foci (FFs), lymphoid aggregates (LAs), and the presence of nonspecific interstitial pneumonia pattern. Design.-Thirty-five patients with histologic diagnoses of UIP were identified (27 biopsies [77%]; 8 explants [23%]). Biopsy slides were scanned and analyzed quantitatively for FF size, FF area, LA size, and LA area. Biopsy and explant slides were examined qualitatively for the presence of a nonspecific interstitial pneumonia pattern in areas away from UIP fibrosis. Results.-Of 27 biopsies, the number and size of FFs in CTD-UIP were smaller than they were in I-UIP. The number and size of LAs were larger in patients with rheumatoid arthritis than they were in patients with I-UIP. There was no interobserver variability among 3 pathologists using this quantitative system. Of 35 biopsies and explants, there was a higher prevalence of the nonspecific interstitial pneumonia pattern among patients with CTD-UIP than there was among patients with I-UIP (P = .005). Conclusions.-Patients with CTD-UIP had fewer, smaller FFs than did patients with I-UIP, and patients with rheumatoid arthritis-UIP had more, larger LAs than did patients with I-UIP. Of importance, the coexistence of UIP and the nonspecific interstitial pneumonia patterns was one of the most salient features in distinguishing CTD-UIP from I-UIP because CTD-UIP demonstrated an increased prevalence of multilobar, cellular, nonspecific interstitial pneumonia patterns in areas away from the UIP fibrosis. (Arch Pathol Lab Med. 2012; 136: 1253-1258; doi: 10.5858/arpa.2012-0102-OA)
引用
收藏
页码:1253 / 1258
页数:6
相关论文
共 50 条
  • [21] Histological Difference Between Idiopathic Interstitial Pneumonias and Connective Tissue Disease-Associated Interstitial Pneumonias
    Dairiki, Mutsumi
    Ichikawa, Hiromi
    Tanaka, Tomonori
    Taniguchi, Hiroyuki
    Johkoh, Takeshi
    Kataoka, Kensuke
    Kondoh, Yasuhiro
    Fukuoka, Junya
    MODERN PATHOLOGY, 2015, 28 : 475A - 475A
  • [22] Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis
    Enomoto, Noriyuki
    Oyama, Yoshiyuki
    Enomoto, Yasunori
    Yasui, Hideki
    Karayama, Masato
    Kono, Masato
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Nakamura, Yutaro
    Suda, Takafumi
    CHRONIC RESPIRATORY DISEASE, 2018, 16
  • [23] Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
    Sanchez Mitacc, Martin Nikolai
    Torres-Zevallos, Hernando
    Albacar, Nuria
    Francesqui, Joel
    Cuerpo, Sandra
    Lucena, Carmen
    Boada, Marc
    Espinosa, Gerard
    Castellanos, Raul
    Vinas, Odette
    Ruiz, Estibaliz
    Perez, Albert
    Agust, Carlos
    Prieto, Sergio
    Ramirez, Jose
    Sanchez, Marcelo
    Hernandez-Gonzales, Fernanda
    Sellares, Jacobo
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [24] Imaging in connective tissue disease-associated interstitial lung disease
    Rao, Praveen R. G.
    Joshi, Kushal
    Liyanage, Sidath
    Dalili, Daniel
    Koduri, Gouri
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (05) : 58 - 68
  • [25] Rituximab for connective tissue disease-associated interstitial lung disease
    Manfredi, Andreina
    Salvarani, Carlo
    Sebastiani, Marco
    LANCET RESPIRATORY MEDICINE, 2023, 11 (01): : 3 - 4
  • [26] Pneumothorax in connective tissue disease-associated interstitial lung disease
    Nishimoto, Koji
    Fujisawa, Tomoyuki
    Yoshimura, Katsuhiro
    Enomoto, Yasunori
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Sumikawa, Hiromitsu
    Johkoh, Takeshi
    Suda, Takafumi
    PLOS ONE, 2020, 15 (07):
  • [27] Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease
    Bonella, Francesco
    Costabel, Ulrich
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (02) : 181 - 200
  • [28] CYCLOPHOSPHAMIDE FOR CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Barnes, H.
    Goh, N.
    Westall, G.
    Holland, A.
    Glaspole, I
    RESPIROLOGY, 2018, 23 : 124 - 124
  • [29] Management of Connective Tissue Disease-associated Interstitial Lung Disease
    Chartrand, Sandra
    Fischer, Aryeh
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (02) : 279 - +
  • [30] Cyclophosphamide for connective tissue disease-associated interstitial lung disease
    Barnes, Hayley
    Holland, Anne E.
    Westall, Glen P.
    Goh, Nicole S. L.
    Glaspole, Ian N.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):